Ifm Investors Pty LTD Neurocrine Biosciences Inc Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Ifm Investors Pty LTD holds 19,459 shares of NBIX stock, worth $2.43 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

19,459

Previous 19,459 -0.0%

Holding current value

$2.43 Million

Previous $2.68 Million 16.36%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$130.86 - $143.19 $102,332 - $111,974	782 Added 4.19%	19,459 $2.68 Million
Q1 2024 Apr 22, 2024	BUY	$130.4 - $143.74 $57,897 - $63,820	444 Added 2.44%	18,677 $2.58 Million
Q3 2023 Oct 26, 2023	BUY	$94.02 - $117.1 $48,044 - $59,838	511 Added 2.88%	18,233 $2.05 Million
Q2 2023 Jul 27, 2023	SELL	$89.53 - $104.87 $1,253 - $1,468	-14 Reduced 0.08%	17,722 $1.67 Million
Q1 2023 May 11, 2023	BUY	$94.11 - $123.02 $131,754 - $172,228	1,400 Added 8.57%	17,736 $1.8 Million
Q4 2022 Feb 14, 2023	SELL	$106.72 - $127.06 $132,973 - $158,316	-1,246 Reduced 7.09%	16,336 $1.95 Million
Q3 2022 Oct 12, 2022	SELL	$92.03 - $107.81 $21,995 - $25,766	-239 Reduced 1.34%	17,582 $1.87 Million
Q2 2022 Jul 15, 2022	SELL	$75.79 - $100.07 $19,856 - $26,218	-262 Reduced 1.45%	17,821 $1.74 Million
Q1 2022 Apr 13, 2022	BUY	$72.45 - $94.81 $178,661 - $233,801	2,466 Added 15.79%	18,083 $1.7 Million
Q4 2021 Jan 18, 2022	BUY	$79.65 - $106.22 $71,923 - $95,916	903 Added 6.14%	15,617 $1.33 Million
Q3 2021 Oct 13, 2021	BUY	$86.18 - $99.03 $63,859 - $73,381	741 Added 5.3%	14,714 $1.41 Million
Q2 2021 Jul 16, 2021	BUY	$89.43 - $102.27 $346,720 - $396,500	3,877 Added 38.4%	13,973 $1.36 Million
Q1 2021 May 05, 2021	BUY	$87.57 - $119.4 $113,140 - $154,264	1,292 Added 14.68%	10,096 $982,000
Q4 2020 Jan 13, 2021	BUY	$86.91 - $108.33 $137,057 - $170,836	1,577 Added 21.82%	8,804 $844,000
Q3 2020 Oct 16, 2020	BUY	$96.16 - $135.15 $68,081 - $95,686	708 Added 10.86%	7,227 $695,000
Q2 2020 Jul 13, 2020	SELL	$85.09 - $130.36 $76,581 - $117,324	-900 Reduced 12.13%	6,519 $795,000
Q1 2020 Apr 09, 2020	SELL	$75.11 - $113.76 $2,553 - $3,867	-34 Reduced 0.46%	7,419 $680,000
Q4 2019 Jan 13, 2020	BUY	$86.8 - $118.57 $646,920 - $883,702	7,453 New	7,453 $801,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Neurocrine Biosciences Inc Transaction History